Marc de Perrot Selected Research

Combined Modality Therapy

1/2021

Triple-modality therapy maximizes antitumor immune responses in a mouse model of mesothelioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc de Perrot Research Topics

Disease

46	Neoplasms (Cancer) 12/2023 - 02/2003
34	Malignant Mesothelioma 12/2023 - 01/2007
31	Pulmonary Hypertension 11/2023 - 04/2006
31	Mesothelioma 12/2022 - 07/2010
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 06/2002
9	Pulmonary Arterial Hypertension 01/2019 - 11/2011
8	Lung Diseases (Lung Disease) 01/2023 - 05/2004
8	Primary Graft Dysfunction 01/2021 - 01/2004
7	Reperfusion Injury 04/2006 - 12/2002
6	Death (Near-Death Experience) 01/2023 - 03/2011
6	Lung Neoplasms (Lung Cancer) 10/2022 - 06/2002
6	Lung Injury 06/2005 - 12/2002
4	Pulmonary Embolism 02/2023 - 09/2007
4	Brain Death (Brain Dead) 01/2023 - 10/2009
4	Heart Failure 01/2022 - 03/2015
4	Bronchogenic Carcinoma 08/2015 - 02/2003
4	Ischemia 12/2005 - 02/2003
3	Inflammation (Inflammations) 01/2023 - 05/2003
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2020
3	Hemorrhage 12/2018 - 05/2007
3	Pleural Effusion (Pleural Effusions) 01/2018 - 10/2012
3	Myasthenia Gravis 02/2017 - 11/2003
2	Hypoxia (Hypoxemia) 02/2023 - 02/2003
2	Hepatitis C 01/2023 - 01/2020
2	Substance-Related Disorders (Drug Abuse) 01/2023 - 09/2014
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 03/2021 - 01/2020
2	Heart Arrest (Cardiac Arrest) 01/2021 - 04/2011
2	Cystic Fibrosis (Mucoviscidosis) 01/2020 - 10/2005
2	Respiratory Insufficiency (Respiratory Failure) 12/2018 - 12/2013
2	Neurofibromatosis 2 (Neurofibromatosis Type II) 11/2017 - 08/2015
2	Pneumothorax 08/2016 - 04/2011
2	Vascular Remodeling 12/2015 - 01/2014
2	Pain (Aches) 01/2015 - 09/2014
2	Bronchiolitis Obliterans Syndrome 12/2013 - 05/2004
2	Familial Primary Pulmonary Hypertension 03/2012 - 09/2011
2	Venous Thromboembolism 11/2011 - 10/2009
2	Pulmonary Edema 04/2011 - 02/2008
2	Edema (Dropsy) 12/2008 - 02/2003
2	Sepsis (Septicemia) 05/2007 - 05/2004
1	Thromboembolism 11/2023
1	Osteosarcoma (Osteogenic Sarcoma) 02/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Marijuana Use 01/2023
1	COVID-19 01/2023
1	Vascular Malformations 01/2023
1	Opiate Overdose 01/2023

Drug/Important Bio-Agent (IBA)

12	AsbestosIBA 12/2023 - 10/2012
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2012
6	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 09/2011
4	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2014
3	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 11/2023 - 01/2022
3	Opioid Analgesics (Opioids)IBA 01/2023 - 09/2014
3	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2012
3	SolutionsIBA 11/2020 - 02/2003
3	Granzymes (Granzyme)IBA 11/2020 - 09/2011
3	Prostaglandins DIBA 01/2017 - 05/2007
3	CytokinesIBA 12/2014 - 09/2011
3	EnzymesIBA 10/2012 - 09/2011
2	NucleotidesIBA 01/2023 - 01/2018
2	Oxygen (Dioxygen)IBA 01/2023 - 04/2011
2	Ribosomal Protein S6IBA 12/2022 - 12/2022
2	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2020
2	Messenger RNA (mRNA)IBA 11/2021 - 11/2019
2	MesothelinIBA 11/2020 - 07/2010
2	dicarboxydine (DCD)IBA 01/2020 - 03/2011
2	Neurofibromin 2 (Merlin)IBA 11/2017 - 08/2015
2	InterferonsIBA 10/2013 - 09/2011
2	ImmunosorbentsIBA 10/2012 - 09/2011
2	PerforinIBA 08/2012 - 09/2011
2	Interleukin-2 (IL2)IBA 08/2012 - 07/2010
2	Bromodeoxyuridine (BrdU)IBA 08/2012 - 09/2011
2	Dihydrotachysterol (AT 10)IBA 04/2012 - 01/2006
1	Transcription Factors (Transcription Factor)IBA 12/2023
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2023
1	mRNA VaccinesIBA 01/2023
1	IodineIBA 01/2023
1	Adenosine DeaminaseIBA 12/2022
1	3' Untranslated Regions (3' UTR)IBA 12/2022
1	Nucleic AcidsIBA 12/2022

Therapy/Procedure

39	Therapeutics 01/2023 - 09/2004
29	Lung Transplantation 01/2023 - 12/2002
22	Endarterectomy (Thromboendarterectomy) 11/2023 - 09/2007
22	Pneumonectomy (Lung Volume Reduction) 01/2021 - 06/2002
15	Radiotherapy 11/2021 - 01/2014
14	Transplantation 01/2021 - 02/2003
11	Drug Therapy (Chemotherapy) 12/2022 - 09/2011
7	Extracorporeal Membrane Oxygenation 01/2022 - 05/2007
7	Induction Chemotherapy 09/2016 - 04/2008
5	Immunotherapy 09/2022 - 08/2012
5	Thymectomy 02/2017 - 11/2002
4	Artificial Respiration (Mechanical Ventilation) 01/2021 - 12/2002
3	Length of Stay 10/2022 - 01/2018
2	Segmental Mastectomy (Lumpectomy) 01/2024 - 11/2014
2	Chest Tubes (Chest Tube) 08/2016 - 04/2011
1	Surgical Amputation (Amputations) 02/2023
1	Adjuvant Chemotherapy 02/2023
1	Ligation 01/2023
1	Radiofrequency Ablation 10/2022
1	Bronchoscopes 10/2022
1	Embolectomy 01/2022